Besifovir dipivoxil maleate versus other antivirals in reducing hepatocellular carcinoma in chronic hepatitis B.

Lee JS, Lee SW, Lee HL, Yoo JJ, Seo YS, Yu SJ, Yim HJ, Jung YK, Moon J, Lee HW, Kim MN, Kim BK, Park JY, Kim DY, Ahn SH, Kim SG, Kim SU

Open source

DOI
10.1038/s41598-025-13456-8
Published
2025 Aug 29
Container
Scientific reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-025-13456-8,
  title = {Besifovir dipivoxil maleate versus other antivirals in reducing hepatocellular carcinoma in chronic hepatitis B.},
  author = {Lee JS and Lee SW and Lee HL and Yoo JJ and Seo YS and Yu SJ and Yim HJ and Jung YK and Moon J and Lee HW and Kim MN and Kim BK and Park JY and Kim DY and Ahn SH and Kim SG and Kim SU},
  year = {2025},
  journal = {Scientific reports},
  doi = {10.1038/s41598-025-13456-8},
  url = {https://doi.org/10.1038/s41598-025-13456-8}
}

RIS

TY  - JOUR
TI  - Besifovir dipivoxil maleate versus other antivirals in reducing hepatocellular carcinoma in chronic hepatitis B.
AU  - Lee JS
AU  - Lee SW
AU  - Lee HL
AU  - Yoo JJ
AU  - Seo YS
AU  - Yu SJ
AU  - Yim HJ
AU  - Jung YK
AU  - Moon J
AU  - Lee HW
AU  - Kim MN
AU  - Kim BK
AU  - Park JY
AU  - Kim DY
AU  - Ahn SH
AU  - Kim SG
AU  - Kim SU
PY  - 2025
JO  - Scientific reports
DO  - 10.1038/s41598-025-13456-8
UR  - https://doi.org/10.1038/s41598-025-13456-8
ER  - 

APA

JS, L., SW, L., HL, L., JJ, Y., YS, S., SJ, Y., HJ, Y., YK, J., J, M., HW, L., MN, K., BK, K., JY, P., DY, K., SH, A., SG, K., & SU, K. (2025). Besifovir dipivoxil maleate versus other antivirals in reducing hepatocellular carcinoma in chronic hepatitis B.. Scientific reports. https://doi.org/10.1038/s41598-025-13456-8

Source records